
Technology Foundation
Sterilization Science
Non-ionizing methodology derived from regulated biological processing.
The Technology
Vaporized hydrogen peroxide delivered under extreme vacuum enables vapor-phase diffusion throughout complex biological material—penetrating beyond surface boundaries into the material matrix.
The controlled vacuum chamber environment ensures consistent distribution and contact. Validated parameters govern exposure duration, concentration, and environmental conditions—producing repeatable, documented outcomes.
Post-process decomposition is complete and chemically irreversible: VHP breaks down entirely to H₂O and O₂—water vapor and oxygen. Zero chemical residue. Zero molecular damage. This is not a trace-level outcome; it is the inherent end-state of the chemistry, and it is why pharmaceutical-grade application is viable.
What It Is Not
—Ionizing radiation
—Ozone-based processing
—Thermal sterilization
—Ambient fogging or misting
—Surface-only decontamination
What It Is
—Controlled vacuum sterilization
—Vapor-phase diffusion process
—Deep penetrative exposure
—Low-temperature compatible
—Decades of validated application
Foundation
Non-Ionizing Process
Microbial disruption without ionizing energy—material chemistry remains unaltered by the process.
Preservation
Material Integrity
Selective action—parameters that microorganisms cannot tolerate but sensitive compounds can.
Validation
Documented Efficacy
Log reduction measured against scientific standards. Repeatable parameters. Consistent outcomes.
Why Non-Ionizing Matters
Ionizing Radiation
Gamma rays, X-rays, and electron beams carry enough energy to break molecular bonds indiscriminately. Effective for sterilization, but can alter material chemistry in unintended ways.
Vacuum-Enabled VHP
VHP delivered under extreme vacuum achieves microbial disruption through deep vapor-phase diffusion—without the penetrating energy that can alter material chemistry. Molecular structure remains intact.
Method Comparison
Not all sterilization methods are equivalent. These distinctions matter at the regulatory level.
| Attribute | TheBOX® (VHP) | Ionizing Radiation | Ozone | Traditional Remediation |
|---|---|---|---|---|
| Pharma heritage | FDA-regulated sterilization | Industrial sterilization | Industrial / water treatment | None |
| Residuals | Zero (H₂O + O₂) | None, but molecular damage | Ozone residuals possible | Chemical residuals |
| Molecular integrity | Preserved | Compromised (bond-breaking) | Surface-only treatment | Variable |
| Audit documentation | Built-in, lot-level | Batch-level at best | Minimal | Typically none |
| Schedule III pathway | Direct (pharma-grade) | Partial | Unlikely | Not applicable |
Selective Action
Microorganisms and plant-derived compounds respond differently to this process. System design exploits this differential susceptibility.

Differential Susceptibility
Microbial structures are vulnerable at concentrations and durations that do not significantly impact cannabinoid or terpene chemistry. This selectivity is the basis of process design.
Parameter Control
• Exposure duration: Managed to achieve efficacy without excess
• Concentration: Maintained within validated range
• Environment: Temperature, humidity, and pressure regulated
Scientific Background
Established Use
VHP sterilization carries 22+ years of FDA-regulated biological processing history. It is not a technology adapted from pharmaceutical applications—it is a pharmaceutical technology, one that has governed sterilization in the most demanding regulated environments on earth. ISO 14937, ISO 22441, and ISO 10993 compliance frameworks were built around it.
• Medical device sterilization: Electronics, polymers, optical components, sensors, and battery-containing devices that cannot tolerate thermal or ionizing methods
• Human tissue processing: Allograft tissue prepared for clinical transplantation under FDA oversight, where irradiation or heat would compromise biological structure and osteoinductive function
• Pharmaceutical manufacturing: Cleanroom and isolator decontamination in environments requiring validated sterility without residue—the standard against which all others are measured
• Hospital environments: Operating suites, patient rooms, and critical care areas where rapid turnaround and material compatibility are required
When the most delicate sterilization challenges arise—across healthcare, pharmaceutical, and advanced manufacturing—VHP is the established methodology of record. TheBOX® brings that same lineage to cannabis.
Cannabis Application
Cannabis presented a constraint-driven engineering problem. Dried flower is a moisture-bearing, chemically volatile botanical material—conditions that commercially available VHP systems are not designed to accommodate. Standard VHP equipment will not initiate in the presence of meaningful residual moisture and lacks the programmability required to adapt to moisture-bearing biological loads.
The core technology was originally developed by PuroGen, the parent company, for human tissue sterilization in the transplant industry. Human allograft tissue presented similar preservation constraints: moisture sensitivity and the requirement to preserve osteoinductivity and osteoconductivity—biological properties essential to surgical outcomes.
The parallel between preserving biological performance in tissue and preserving terpenes, cannabinoids, and moisture behavior in cannabis informed the engineering approach. TheBOX® was purpose-engineered to operate in moisture-bearing biological materials using controlled vapor-phase diffusion under extreme vacuum—achieving microbial elimination alongside preservation, not at the expense of it.
Adaptation of this technology to cannabis began in 2015. More than 100 units have since been deployed across U.S. and international markets.
Reactive Oxygen®
Reactive Oxygen® is the branded name for the proprietary reagent and process framework integrated within TheBOX® system. It does not refer to uncontrolled reactive oxygen species and should not be interpreted as free-radical chemistry.
Within the Reactive Oxygen® framework, reactive activity is intentionally generated, transient, and spatially constrained—a function of defined process conditions rather than ambient chemical behavior. Microbial control is system-mediated: governed by chamber architecture, parameter control, and exposure boundaries—not by chemical aggressiveness alone. The extreme vacuum conditions also function as a preventative mechanism: by removing atmospheric oxygen and collapsing the physical environment that supports microbial respiration and colonization, the chamber creates conditions hostile to microbial survival before oxidative activity begins. Prevention and elimination are simultaneous, not sequential.
VHP undergoes complete decomposition at the close of every cycle—breaking down entirely into water vapor (H₂O) and oxygen (O₂). No chemical byproducts. No residual compounds on processed material. This is not a performance claim; it is the known end-state of the chemistry, independently verifiable, and the reason zero-residual sterilization is achievable at all.
The result is predictable, repeatable sterilization outcomes with material preservation as a design constraint, not a trade-off.
Non-ionizing
No material-altering radiation
VHP-based
Controlled reagent delivery
Zero residuals
Decomposes completely to H₂O + O₂ — no chemical trace
Deep diffusion
Vacuum-enabled penetration
Material preservation
Compound integrity maintained
System-mediated
Architecture-governed outcomes
Validation Philosophy
Demonstrating that a process consistently produces intended outcomes under defined conditions.
Log Reduction
Microbial reduction expressed in logarithmic terms—1-log represents 90% decrease; 3-log represents 99.9%. A scientific convention for standardized comparison.
Repeatability
Process parameters controlled with sufficient precision that the same inputs yield the same results across cycles, units, and facilities.
Documentation
Cycle parameters, lot identification, and process conditions captured and retained—the foundation of defensible claims about outcomes.
Consistency
System design, automation, and operator controls that translate validated parameters to real-world consistency.
Scope of Validation
Documented evidence across system efficacy, safety, and operational constraints.
System Efficacy
Biological Indicator Validation
—Industry-standard biological indicators
—Empty chamber testing (material-independent)
—~1,000,000 CFU (~6-log) reduction per cycle
—Demonstrates system capability
Internal Field Testing
—Internal plating within licensed operations
—Observed reductions: ~450,000 to 1,000,000 CFU
—Operational confirmation, not lab certification
—Material-dependent outcomes expected
Regulatory Testing Constraints
THC-containing cannabis cannot be sent to most accredited microbiology institutions. Controlled substance handling restrictions limit conventional third-party validation pathways. This structural constraint applies industry-wide and is not unique to any single manufacturer or system.
Material Variability
What Varies
—Flower density, porosity, internal structure
—Diffusion-dependent behavior in vapor-phase processes
—Heterogeneous biological material
What Does Not Vary
—System capability is constant
—Process parameters are governed
—Observed outcomes reflect material properties
Safety Validation
Human & Environmental
No residual compounds; decomposes to water and oxygen
Product Safety
Material integrity preserved; no ionizing energy
Biological Safety
Process does not alter molecular chemistry
Declared Validations
Third-party studies conducted under recognized standards and protocols.
The process is validated. The parameters are documented. The outcomes are repeatable.
This is the scientific foundation. TheBOX® is the system that implements it for regulated cannabis operations.
Process Control for Regulated Cannabis Operations